Summit on Access and Affordability in Cell and Gene Therapies
Program Description: As cell and gene therapies move from experimental treatments to approved interventions, the healthcare community faces a critical challenge: ensuring these groundbreaking therapies reach patients who need them most.
This summit brings together senior leaders in research, clinical practice, market access, policy, and patient advocacy to address the urgent need for sustainable pricing models, scalable manufacturing approaches, regulatory strategies, and innovative financing mechanisms. Through collaborative dialogue, we aim to balance continued innovation with the fundamental principle that medical breakthroughs should benefit all patients, regardless of economic circumstances or geographic location.
Summary of Sessions
- Strategies for Reducing Risks and Addressing Commercial Insurer Participation
- Emerging Policy for New Cell and Gene Therapy Affordability Models
- Manufacturing and Regulatory Innovations
Registration is by invitation. Invited attendees will receive an email communication outlining the registration process.